Viroclinics Biosciences is a leading diagnostic and clinical trial operation service company providing diagnostic and preclinical studies along with drug development for prevention and treatment of virus infections
Location: Netherlands, South Holland, Rotterdam
Employees: 51-200
Founded date: 2000
Investors 3
| Date | Name | Website |
| - | ECE Campus | ece.nl |
| - | Gilde Heal... | gildehealt... |
| - | Summit Par... | summitpart... |
Mentions in press and media 3
| Date | Title | Description |
| 16.12.2021 | Cerba Healthcare to Acquire Viroclinics-DDL Expanding and Transforming Its Offering in Clinical Trials | • The acquisition illustrates the Group's strategy to strengthen its position in the entire value chain of diagnosis and stresses the pivotal role of clinical trial services. • It offers Viroclinics-DDL a broader range of capabilities in it... |
| 14.04.2021 | Translating SARS-CoV-2 Clinical Trial Challenges Into Lasting Solutions, Upcoming Webinar Hosted by Xtalks | As there are many different therapeutic and prophylactic approaches against SARS-CoV-2, there is a need for a wide array of preclinical and clinical trial diagnostic research methods. TORONTO (PRWEB) April 14, 2021 As SARS-CoV-2 continues t... |
| 09.01.2014 | Viroclinics Biosciences Receives Majority Investment from Gilde Healthcare Services | Viroclinics Biosciences, a Rotterdam, the Netherlands-based virology contract research organization, received a majority investment from Gilde Healthcare Services. The amount of the deal was not disclosed. Founded in 2001 as a spin-off from... |